Stock Comparison
ABT vs GMED
Abbott Laboratories and Globus Medical side by side — valuation, profitability, growth and risk.
Valuation
Market Cap
$163.94B
$11.71B
P/E (TTM)
26.4
20.2
Forward P/E
17.2
19.0
Price/Sales
3.6
3.8
Price/Book
3.2
2.5
EV/EBITDA
16.1
12.7
Dividend Yield
2.62%
—
Profitability
Net Margin
13.90%
18.90%
Operating Margin
13.50%
21.30%
Return on Equity
12.30%
13.30%
Return on Assets
5.59%
8.18%
Growth (YoY)
Revenue Growth
7.80%
27.00%
Earnings Growth
-19.70%
66.70%
Price & Risk
Beta
0.6
1.0
52-Week High
$135.34
$101.40
52-Week Low
$81.97
$51.79
Analyst Target
$116.54
$108.64
Compare ABT and GMED your own way
Try mrmarket.ai freeFigures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.